Arcadia Biosciences Cash Flow - Quarterly (NASDAQ:RKDA)

Add to My Stocks
$0.94 $0.01 (1.18%) RKDA stock closing price Jan 23, 2017 (Closing)

The cash flow statement is one of the reports a publicly traded company like Arcadia Biosciences needs to disclose. While its important to look at the Arcadia Biosciences debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Arcadia Biosciences revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. The cash flow statement is essetial while conducting the Arcadia Biosciences cash flow analysis and can be used to measure the operating performance of Arcadia Biosciences compared to various industry peers like ANDE stock and YONG stock. The cash from operating activities for Arcadia Biosciences is $-12.77M for 2016-Q3, which saw a decrease of 44.46% from previous quarter. View details of Arcadia Biosciences cash flows for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
Arcadia Biosciences Net Income Cash Flow
-13.91M-9.74M-5.19M-17.95M-14.09M-9.48M-5.8M-18.33M-16.35M-9.28M
Depreciation Depletion Amortization Cash-Flow0.34M0.28M0.14M0.37M0.21M0.14M0.07M0.35M0.27M0.18M
Net Increase (Decrease) in Assets Liabilities-0.01M0.11M-0.07M-0.05M0.52M0.81M1.2M-1.33M-0.08M-0.85M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net0.8M0.49M0.26M2.52M2.2M1.93M1.92M4.53M4.03M1.53M
Arcadia Biosciences Net Cash from (used by) Operating Activities
-12.77M-8.84M-4.85M-15.1M-11.16M-6.58M-2.59M-14.78M-12.12M-8.42M
Increase (Decrease) in Prop Plant And Equipment-0.22M-0.19M-0.13M-0.14M-0.08M-0.02M-0.01M-0.14M-0.03M-
Acquisition Disposition of Subsidiaires--------1.45M-1.45M-0.95M
Increase (Decrease) in Investments-0.88M12.2M10.46M-46.21M-11.29M-----
Other Cash Inflow (Outflow) from Investment Activities----------
Arcadia Biosciences Net Cash from (used by) Invesment Activities
-1.1M12M10.32M-46.36M-11.37M-0.02M-0.01M-1.59M-1.48M-0.94M
Issuance (Purchase) of Equity Shares0.42M0.27M0.13M68.58M68.39M68.25M-32.86M32.85M32.84M
Issuance (Repayment) of Debt Securities---10.2M8.87M8.87M-1.45M-1.15M-0.89M-0.63M
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.04M-0.04M-0.04M-9.92M-8.34M-7.09M-1.23M-1.59M-0.01M-
Arcadia Biosciences Net Cash from (used by) Financing Activities
0.38M0.22M0.09M68.87M68.92M70.03M-2.68M30.11M31.94M32.21M
Effect of Exchange Rate Changes on Cash----------
Arcadia Biosciences Net Change in Cash & Cash Equivalents
-13.5M3.38M5.56M7.4M46.39M63.43M-5.29M13.73M18.33M22.84M
Cash & Equivalents at Beginning of Year16.57M2.83M5.35M-------
Cash & Equivalents at Year End10.47M27.36M29.54M23.97M62.96M80M11.27M16.57M21.17M25.67M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Cash flow for another ticker

Arcadia Biosciences stock comparison chart provides an easy way to compare the stock price with peers along with details of Arcadia Biosciences stock price history.
The statement of cash flows can be categorized into three main sections:
  • Arcadia Biosciences had a Net Change in Cash and Cash Equivalents of $-13.5M for the latest quarter 2016-Q3. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Arcadia Biosciences stock price , albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-12.77M for RKDA.
  • Growth companies (typically most tech companies) spend heavily  on investing activities and this figure was negative at $-1.1M for RKDA stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $0.38M for Arcadia Biosciences. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.
.

Key Financial Ratios For Arcadia Biosciences Cash Flow

FCF margin
-3.67